http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-203447425-U
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b93c2aafeb1bcb1019daee345cc8f141 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
filingDate | 2013-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0a18a3c48a66fda20352050fcbd4e49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a022029faba8be73fbfc4a760fc20eb9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f54e3dc2de097e4519d55e6bdd7bf44a |
publicationDate | 2014-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-203447425-U |
titleOfInvention | Vitreous chamber injection fixator |
abstract | The utility model discloses a vitreous chamber injection fixator comprising a concave surface fixing piece, a hollow metal pipe into which a syringe needle is inserted is arranged on the convex surface of the concave surface fixing piece perpendicularly, and the periphery of the concave surface fixing piece is in a concave arc shape. The curvature radius of the concave surface fixing piece is 10-15mm, the height of the hollow metal pipe is 5mm, the inner diameter of the metal pipe is 0.3-0.4mm, outer sleeves made of elastic silica gel materials tightly wrap the inner surface and the outer surface of the hollow metal pipe and the surface of the concave surface fixing piece, and the different distances between the center of the hollow metal pipe to the limbus corneae are selected by different patients. When the vitreous chamber injection fixator is used and placed, the tunica conjunctiva is pushed, then injection is fixed, the sclera injection point on the lower portion and the tunica conjunctiva injection point on the upper portion are not on the same point after the fixator is pulled out, the tunica conjunctiva which bounces back covers the sclera injection point, the intraocular exposure is reduced, and the endophthalmitis is reduced. |
priorityDate | 2013-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758 |
Total number of triples: 15.